On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Cobra Biologics Limited's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€579k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- ELIMOXPartner
Biopharmaceutical therapy for treatment of Primary Hyperoxaluria
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€579ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNONetherlands · 1 shared project
- Universitatsklinikum BonnGermany · 1 shared project
- Hospices Civils de LyonFrance · 1 shared project
- University College London Hospitalsnhs Foundation TrustUnited Kingdom · 1 shared project
- Oxthera ABSweden · 1 shared project
- Symbio Pharm GmbHGermany · 1 shared project
- K.a.b.s. Laboratories Inc. - KabsCanada · 1 shared project
- Medizinisches Versorgungszentrum Institut Fur Mikrookologie GmbHGermany · 1 shared project
- Bio-Images Research LimitedUnited Kingdom · 1 shared project
- Galenica ABSweden · 1 shared project
- Ergomed Clinical Research LimitedUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- bacteriology
- manufacturing engineering
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗